Company Information

STRIDES PHARMA SCIENCE LTD.

NSE : STARBSE : 532531ISIN CODE : INE939A01011Industry : Pharmaceuticals & DrugsHouse : Private
BSE843.00-1.05 (-0.12 %)
PREV CLOSE ( ) 844.05
OPEN PRICE ( ) 845.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 26553
TODAY'S LOW / HIGH ( )826.45 864.10
52 WK LOW / HIGH ( )306.9 864.1
NSE843.45-1.4 (-0.17 %)
PREV CLOSE( ) 844.85
OPEN PRICE ( ) 844.85
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 843.45 (335)
VOLUME 316272
TODAY'S LOW / HIGH( ) 827.40 863.65
52 WK LOW / HIGH ( )306.9 865
ChairmanArun Kumar
Managing DirectorArun Kumar
Company SecretaryManjula Ramamurthy
Executive Director - FinanceBadree Komandur
Non Executive Independent DirectorKausalya Santhanam
S Sridhar
Bharat D Shah
Homi Rustam Khusrokhan
Incorporation Year : 28-06 1990

Registered Office :

Address : 201, Devavrata,Sector-17,Vashi Navi Mumbai,
Maharashtra-400703 .

Phone : 022-27892924 / 3199

Email :  corpcomm@strides.com 

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE,MCX

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.